Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1983 2
1984 3
1985 4
1986 5
1987 3
1988 2
1989 6
1990 4
1991 2
1992 2
1993 3
1994 4
1997 1
1998 1
1999 1
2003 1
2004 1
2005 1
2006 3
2008 2
2009 1
2010 3
2013 4
2014 1
2015 2
2016 2
2017 3
2018 2
2019 1
2020 1
2021 2
2022 6
2023 3
2024 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P; SONIC Study Group. Colombel JF, et al. N Engl J Med. 2010 Apr 15;362(15):1383-95. doi: 10.1056/NEJMoa0904492. N Engl J Med. 2010. PMID: 20393175 Free article. Clinical Trial.
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Biologic therapy in inflammatory bowel disease.
Theede K, Dahlerup JF, Fallingborg J, Hvas CL, Kjeldsen J, Munck LK, Nordgaard-Lassen I; Danish Society of Gastroenterology and Hepatology. Theede K, et al. Among authors: fallingborg j. Dan Med J. 2013 Jun;60(6):B4652. Dan Med J. 2013. PMID: 23743116 Free article.
Azathioprine treatment during lactation.
Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Christensen LA, et al. Among authors: fallingborg jf. Aliment Pharmacol Ther. 2008 Nov 15;28(10):1209-13. doi: 10.1111/j.1365-2036.2008.03843.x. Epub 2008 Aug 30. Aliment Pharmacol Ther. 2008. PMID: 18761704
Campylobacter pylori in esophagus.
Fallingborg J, Agnholt J, Møller-Petersen J, Christensen LA, Lomborg S, Søndergaard G, Teglbjaerg PS, Rasmussen SN. Fallingborg J, et al. Dig Dis Sci. 1989 Nov;34(11):1802-3. doi: 10.1007/BF01540063. Dig Dis Sci. 1989. PMID: 2582992 No abstract available.
[Primary sclerosing cholangitis].
Rasmussen HH, Fallingborg JF, Mortensen PB, Freund LG, Tage-Jensen U, Rasmussen SN. Rasmussen HH, et al. Among authors: fallingborg jf. Ugeskr Laeger. 1991 May 20;153(21):1487-91. Ugeskr Laeger. 1991. PMID: 2053198 Review. Danish.
[Behçet's syndrome].
Fallingborg J. Fallingborg J. Ugeskr Laeger. 1986 Mar 24;148(13):757-9. Ugeskr Laeger. 1986. PMID: 3705211 Danish. No abstract available.
80 results